Market Overview:
The global hospital acquired disease testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of hospital-acquired infections (HAIs), growing demand for drug-resistance testing, and technological advancements in diagnostic instruments and reagents. In terms of type, the market is segmented into instrument and reagents, and consumables. The instrument and reagents segment accounted for the largest share of the global hospital acquired disease testing market in 2017 owing to the increasing demand for advanced diagnostic instruments and rising prevalence of HAIs. In terms of application, the market is divided into disease testing and drug-resistance testing.
Product Definition:
Hospital Acquired Disease Testing is the process of testing for infections or other diseases that may have been contracted while a person is in the hospital. The importance of Hospital Acquired Disease Testing is to help identify and treat any infections or diseases as quickly as possible.
Instrument and Reagents:
Instrument and reagents are the two key elements of hospital-acquired disease testing market. The growth factor for this market is mainly due to the growing prevalence of Hospital Acquired Infections (HAIs). According to CDC, about 1 in 25 hospital patients has at least one healthcare-associated infection every year. Moreover, as per a study conducted by University of California San Francisco in 2015, more than half a million people die each year from HAI around the world.
Consumables:
The global consumables and it's usage in hospital-acquired disease testing market size was valued at USD 8.5 billion in 2016. It is expected to witness a CAGR of XX% during the forecast period, owing to increasing prevalence of hospital acquired infections (HAIs).
Application Insights:
The disease testing segment dominated the global hospital acquired disease testing market in 2017. This can be attributed to the rising prevalence of hospital-acquired infections and increasing awareness among hospitals regarding early detection of these infections. For instance, according to a study published by NCBI in 2018, around 23% of patients acquire Methicillin-resistant Staphylococcus aureus (MRSA) infection during their stay in hospitals. Thus, it is important for healthcare providers to identify these bacteria so that appropriate measures can be taken against them.
Drug resistance testing is expected to grow at a lucrative rate over the forecast period owing to its ability as one of the most effective tools for detecting drug-resistant bacteria and viruses within hours instead of days or weeks as seen with other tests such as culture or susceptibility tests done traditionally before an antibiotic could be used safely againts bacterial infection.
Regional Analysis:
North America dominated the global hospital acquired disease testing market in 2017. This can be attributed to favorable government initiatives, high healthcare expenditure and availability of advanced diagnostic technologies. Moreover, an increase in the number of patients with chronic diseases is also expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure and rising patient awareness regarding early diagnosis of HAIs. Furthermore, a rise in international travel for medical reasons has increased chances of exposure to these infections across this region which will further boost demand for tests during the forecast period.
Growth Factors:
- Increasing incidence of hospital acquired diseases (HAD) is one of the major growth drivers for the global hospital acquired disease testing market. According to a study by Centers for Disease Control and Prevention (CDC), around 1 in 25 patients admitted in hospitals across the U.S. are affected by HAD, which leads to increased mortality rates, longer hospital stays, and increased healthcare costs.
- The increasing demand for rapid diagnosis and treatment of HAD is another major growth driver for this market. Most of the time, patients admitted in hospitals are already suffering from advanced stages of infection that require immediate diagnosis and treatment. Hence, there is a growing demand for rapid diagnostic tests that can provide results within minutes or hours instead of days or weeks required by traditional methods such as culture-based tests or polymerase chain reaction (PCR).
- The increasing number of mergers and acquisitions among diagnostic companies is also fueling the growth of this market as it leads to development & commercializationof new products & technologies catering to the needs o fhospitalacquired disease testing market . For instance , In March 2017 , Alere Inc., a leading provider if point-of-care diagnostics solutions, agreed to be acquiredby Abbott Laboratoriesfor .8 billion . This acquisition will help Abbott expand its presence in fast-growing markets such as infectious diseasesand cardiology .
Scope Of The Report
Report Attributes
Report Details
Report Title
Hospital Acquired Disease Testing Market Research Report
By Type
Instrument and Reagents, Consumables
By Application
Disease Testing, Drug-Resistance Testing
By Companies
Life technologies, Diatherix laboratories, Qiagen GmbH, Meridian Biosciences, Nordion, Roche, Cantel Medical Corporation, Cepheid
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
162
Number of Tables & Figures
114
Customization Available
Yes, the report can be customized as per your need.
Global Hospital Acquired Disease Testing Market Report Segments:
The global Hospital Acquired Disease Testing market is segmented on the basis of:
Types
Instrument and Reagents, Consumables
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Disease Testing, Drug-Resistance Testing
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Life technologies
- Diatherix laboratories
- Qiagen GmbH
- Meridian Biosciences
- Nordion
- Roche
- Cantel Medical Corporation
- Cepheid
Highlights of The Hospital Acquired Disease Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Instrument and Reagents
- Consumables
- By Application:
- Disease Testing
- Drug-Resistance Testing
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hospital Acquired Disease Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hospital acquired disease testing is a process that is used to identify and treat infections that are acquired while a patient is in the hospital. This testing can include tests for bacteria, viruses, and fungi.
Some of the major players in the hospital acquired disease testing market are Life technologies, Diatherix laboratories, Qiagen GmbH, Meridian Biosciences, Nordion, Roche, Cantel Medical Corporation, Cepheid.
The hospital acquired disease testing market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hospital Acquired Disease Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hospital Acquired Disease Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hospital Acquired Disease Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hospital Acquired Disease Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hospital Acquired Disease Testing Market Size & Forecast, 2018-2028
4.5.1 Hospital Acquired Disease Testing Market Size and Y-o-Y Growth
4.5.2 Hospital Acquired Disease Testing Market Absolute $ Opportunity
Chapter 5 Global Hospital Acquired Disease Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Hospital Acquired Disease Testing Market Size Forecast by Type
5.2.1 Instrument and Reagents
5.2.2 Consumables
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Hospital Acquired Disease Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Hospital Acquired Disease Testing Market Size Forecast by Applications
6.2.1 Disease Testing
6.2.2 Drug-Resistance Testing
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hospital Acquired Disease Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hospital Acquired Disease Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Hospital Acquired Disease Testing Analysis and Forecast
9.1 Introduction
9.2 North America Hospital Acquired Disease Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Hospital Acquired Disease Testing Market Size Forecast by Type
9.6.1 Instrument and Reagents
9.6.2 Consumables
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Hospital Acquired Disease Testing Market Size Forecast by Applications
9.10.1 Disease Testing
9.10.2 Drug-Resistance Testing
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Hospital Acquired Disease Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Hospital Acquired Disease Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Hospital Acquired Disease Testing Market Size Forecast by Type
10.6.1 Instrument and Reagents
10.6.2 Consumables
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Hospital Acquired Disease Testing Market Size Forecast by Applications
10.10.1 Disease Testing
10.10.2 Drug-Resistance Testing
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Hospital Acquired Disease Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Hospital Acquired Disease Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Hospital Acquired Disease Testing Market Size Forecast by Type
11.6.1 Instrument and Reagents
11.6.2 Consumables
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Hospital Acquired Disease Testing Market Size Forecast by Applications
11.10.1 Disease Testing
11.10.2 Drug-Resistance Testing
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Hospital Acquired Disease Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Hospital Acquired Disease Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Hospital Acquired Disease Testing Market Size Forecast by Type
12.6.1 Instrument and Reagents
12.6.2 Consumables
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Hospital Acquired Disease Testing Market Size Forecast by Applications
12.10.1 Disease Testing
12.10.2 Drug-Resistance Testing
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Hospital Acquired Disease Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Hospital Acquired Disease Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Hospital Acquired Disease Testing Market Size Forecast by Type
13.6.1 Instrument and Reagents
13.6.2 Consumables
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Hospital Acquired Disease Testing Market Size Forecast by Applications
13.10.1 Disease Testing
13.10.2 Drug-Resistance Testing
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hospital Acquired Disease Testing Market: Competitive Dashboard
14.2 Global Hospital Acquired Disease Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Life technologies
14.3.2 Diatherix laboratories
14.3.3 Qiagen GmbH
14.3.4 Meridian Biosciences
14.3.5 Nordion
14.3.6 Roche
14.3.7 Cantel Medical Corporation
14.3.8 Cepheid
